IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 84 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,910,247 | +63.0% | 1,707,394 | +152.0% | 0.01% | +66.7% |
| Q3 2022 | $6,694,000 | +74.4% | 677,579 | +194.9% | 0.00% | +50.0% |
| Q1 2022 | $3,839,000 | +52.9% | 229,734 | +78.0% | 0.00% | +100.0% |
| Q4 2021 | $2,510,000 | -29.3% | 129,063 | -3.7% | 0.00% | -50.0% |
| Q2 2021 | $3,550,000 | +2529.6% | 134,046 | +3021.0% | 0.00% | – |
| Q1 2021 | $135,000 | -20.1% | 4,295 | +30.1% | 0.00% | – |
| Q4 2020 | $169,000 | +207.3% | 3,301 | +69.5% | 0.00% | – |
| Q3 2020 | $55,000 | -6.8% | 1,948 | +0.8% | 0.00% | – |
| Q2 2020 | $59,000 | -75.4% | 1,933 | -76.7% | 0.00% | – |
| Q1 2020 | $240,000 | -44.4% | 8,313 | -46.8% | 0.00% | – |
| Q4 2019 | $432,000 | +92.0% | 15,632 | +26.1% | 0.00% | – |
| Q3 2019 | $225,000 | -23.2% | 12,394 | +3.8% | 0.00% | – |
| Q2 2019 | $293,000 | +1231.8% | 11,937 | +410.6% | 0.00% | – |
| Q1 2019 | $22,000 | -33.3% | 2,338 | -39.0% | 0.00% | – |
| Q4 2018 | $33,000 | +3.1% | 3,833 | +31.9% | 0.00% | – |
| Q3 2018 | $32,000 | -36.0% | 2,905 | -25.9% | 0.00% | – |
| Q2 2018 | $50,000 | -10.7% | 3,922 | +17.5% | 0.00% | – |
| Q1 2018 | $56,000 | +700.0% | 3,338 | +298.3% | 0.00% | – |
| Q4 2017 | $7,000 | -36.4% | 838 | -38.5% | 0.00% | – |
| Q3 2017 | $11,000 | +83.3% | 1,363 | +62.6% | 0.00% | – |
| Q2 2017 | $6,000 | – | 838 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |